Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 & The Gut Brain Axis: A Practitioner's Definitive Review of the Evidence BPC 157 Benefits, Dosage & Before After Results